Skip to main content

Table 1 Classification of two RCC sets and their clinical characteristics

From: Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome

  

RCC microarray set

RCC TMA set

  

A

B

C

 

A

B

C

 
  

N (%)

N (%)

N (%)

N (total)

N (%)

N (%)

N (%)

N (total)

Histological

ccRCC

48 (65)

16 (22)

10 (13)

74

39 (27)

66 (45)

41 (28)

146

subtype

pRCC

1 (5)

6 (32)

12 (63)

19

0

17 (52)

16(48)

33

 

chRCC

0

1 (50)

1 (50)

2

0

7 (70)

3 (30)

10

 

cc/pRCC

0

0

2 (100)

2

-

-

-

-

Tumor stage

pT1/pT2

32 (52)

16 (26)

14 (22)

62

27 (28)

48 (51)

20 (21)

95

 

pT3/pT4

17 (49)

7 (20)

11 (31)

35

12 (14)

39 (45)

36 (41)

87

Fuhrman grade

grade 1

3 (43)

1 (14)

3 (43)

7

1 (100)

0

0

1

 

grade 2

27 (63)

8 (19)

8 (19)

43

20 (36)

20 (36)

15 (27)

55

 

grade 3

18 (44)

12 (29)

11 (27)

41

16 (20)

44 (55)

20 (25)

80

 

grade 4

1 (17)

2 (33)

3 (50)

6

2 (4)

24 (47)

25 (49)

51

sarcomatoid

yes

nd

nd

nd

 

3 (7)

20 (43)

23 (50)

46

 

no

nd

nd

nd

 

36 (26)

67 (48)

37 (26)

140

  1. nd: not done due to limited tissue material.